Medical Artificial Intelligence (MEDai, Inc.®) was founded in 1988 by Steve Epstein, CEO and Diane Lee, Executive Vice President and incorporated in the state of Florida in 1992. The corporation's basis of belief is the utilization of computer intelligence information and applying this to the medical industry creating better quality healthcare outcomes while reducing costs.

MEDai, Inc. is a leading health information company, offering award-winning solutions to the payor and provider markets. These processes provide healthcare providers solutions that incorporate disease focused severity adjustment, benchmarking and evidence-based processes of care to improve outcomes in a hospital-based setting. Payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes.

MEDai supplies six major products to the healthcare industry:

1. Risk Navigator Clinical^® - an application for managed care organizations, insurers or disease management companies which identifies those members who are at highest risk for future healthcare cost, and allows the users to profile these members by disease, employer group, drug group, etc.
2. Risk Navigator Performance™ -a product, which incorporates retrospective utilization profiling and risk information. Provider performance can be measured against national and regional benchmarks. Key information includes Case Mix Index, Efficiency Index and Episode evaluation of potential savings
3. Risk Navigator Financial™- an application, which provides actuarial and underwriting reporting functionality, cost predictions, and modeling flexibility. Historical trends in cost, utilization and risk by group and renewal date, combined with predictive capabilities, make this a very powerful tool for Actuarial and Underwriting teams.
4. Risk Navigator Provider™-an application for clinicians and/or office managers with the ability to retrieve information for a specific patient, obtain a list of all patients' evidence-based medicine compliance, and review utilization performance. Disease and diagnosis reports at aggregate and individual patient levels are also available.
5. Pinpoint Quality ™ - application, which provides clinically relevant data for clinicians to improve care, patient satisfaction and operational efficiency by incorporating severity adjustment strategies with Intelligent data management approach to provide the best data for decision-making.
6. Pinpoint Compliance™ - a product, which complements PPQ and meets JCAHO ORYX guidelines.
7. Risk Navigator Reporter™- application, which provides additional ad-hoc reporting capabilities for each module via the Cognos Powerplay Product.

Steve Epstein
Chief Executive Officer (Co-Founder)

With over 31 years of experience in computers and health care, Mr. Epstein has developed an in-depth understanding of healthcare databases and is recognized as a pioneer and expert in neural networks and abductive/induction systems for health care. He has published over 17 articles and presented his work in numerous healthcare and technical symposiums. In addition, Mr. Epstein's Outcomes Measurement Process was acclaimed, in 1994, as an innovation by the American College of Physician Executives. MEDai won the 1994 Healthcare Innovations in Technology Systems (HITS) Partnership Award for its Myocardial Infarction (MI) Predictor, a program used to determine whether or not a patient is having a heart attack. In 1997, MEDai's High Risk Predictor was a runner up for the HITS award making MEDai the only company to ever be a two-time finalist for the award. In 1997, MEDai and Sentara Healthcare jointly won the ComputerWorld Smithsonian Award for their project entitled, "Clinical Care Improvements Using Artificial Intelligence Disease Analysis." In 2000 and again in 2001, MEDai was named as one of central Florida's fastest growing technology companies by Deloitte and Touche as part of their "Fast 50" program.

Diane Lee
Executive Vice President (Co-Founder)

Along with Mr. Epstein, Ms. Lee is credited with developing and implementing the first for-profit home health agency east of the Mississippi. With 20 years of combined healthcare management and data analysis experience, she is an expert in clinical and financial decision support systems, TQM applications, severity adjustment processes, data scrubbing techniques, and clinical pathway application. In 1988, Ms. Lee co-founded MEDai, Inc., together with Mr. Epstein. Ms. Lee led the development of MEDai's Clinical Decision Support System software, High Risk Predictor software, and severity and risk adjustment statistical applications. These tools were integral in winning the ComputerWorld Smithsonian award for MEDai and Sentara in 1997.

Swati Abbott
President

Ms. Abbott joined MEDai bringing extensive experience in healthcare setting. Identifying, negotiating and securing long-term relationships provided Ms. Abbott with in-depth experience developing strategic relationships and market positioning. During her two years as Managing Director for the Medical Management Strategic Business Unit at ViPS, Ms. Abbott's focus was to provide strategic customer and market driven focus to each of the companies product focus.